Source:http://linkedlifedata.com/resource/pubmed/id/16255536
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-10-31
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1682-8658
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-41
|
pubmed:meshHeading |
pubmed-meshheading:16255536-Adult,
pubmed-meshheading:16255536-Betaine,
pubmed-meshheading:16255536-Dyspepsia,
pubmed-meshheading:16255536-Female,
pubmed-meshheading:16255536-Humans,
pubmed-meshheading:16255536-Male,
pubmed-meshheading:16255536-Stomach Diseases,
pubmed-meshheading:16255536-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
[New alternative drug therapy for reducing symptoms associated with the functional gastric disorders].
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|